Results 321 to 330 of about 260,030 (390)
Exploring exosome profiling via CytoFLEX Nano flow cytometer: Approaches and applications
This study evaluated CytoFLEX Nano flow cytometer's exosome detection performance, comparing it with traditional CytoFLEX in sensitivity, repeatability, and fluorescence labeling. Notably, the CytoFLEX Nano demonstrates distinct advantages: enhanced sensitivity, improved selectivity, and expanded applicability.
Li Cao +10 more
wiley +1 more source
PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5-KRAS Crosstalk. [PDF]
Spivak M +4 more
europepmc +1 more source
Organoid‐based novel technology for antitumor drug screening
Organoids represent a cutting‐edge research model that closely mimics in vivo organ physiology, making them highly valuable for tumor immunotherapy drug screening. This review explores the integration of organoids with advanced technologies, such as gene editing, 3D bioprinting, and AI, highlighting novel fusion platforms and their applications.
Yu Su +3 more
wiley +1 more source
Structural basis for LZTR1 recognition of RAS GTPases for degradation. [PDF]
Dharmaiah S +11 more
europepmc +1 more source
ABSTRACT Objectives Acquired cholesteatoma is an abnormal and invasive growth of keratinized squamous epithelial cells in the middle ear. The study aims to explore the role of exosomal miRNAs in the pathogenesis of acquired cholesteatoma and their potential in clinical application.
Qi Tang +12 more
wiley +1 more source
KRAS: the Achilles' heel of pancreas cancer biology. [PDF]
Drizyte-Miller K +4 more
europepmc +1 more source
When Do Supply Chain Employees Feel Responsible for Proactively Engaging in Greening Behaviours?
Abstract Employees in supply chain (SC) functions are increasingly assigned sustainability‐related responsibilities and expected to engage in green behaviours. While prior research distinguishes voluntary from required green behaviours, the SC context suggests that employees perceive varying degrees of voluntariness and obligation.
Savita Verma +2 more
wiley +1 more source
Oncogenic driver mutations underlie the spatial tumour immune landscape of non-small cell lung cancer. [PDF]
Hartner S +16 more
europepmc +1 more source
ABSTRACT Objective To determine the effectiveness and cost‐effectiveness of multi‐gene panel sequencing compared to single‐gene KRAS testing for metastatic colorectal cancer (mCRC). Study Setting and Design British Columbia, Canada (BC) is a provincial single‐payer public healthcare system, and it was the first province to publicly reimburse multi‐gene
Emanuel Krebs +4 more
wiley +1 more source

